Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cancer Immunology Research|August 14, 2021
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist TherapyLauren Dennison, Amanda Ruggieri, Aditya Mohan, et al.JCI Insight|May 22, 2020
Effects of B cell-activating factor on tumor immunityMark Yarchoan, Won Jin Ho, Aditya Mohan, et al.JCI Insight|October 10, 2022
Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trialsDimitrios N Sidiropoulos, Genevieve L Stein-O'Brien, Ludmila Danilova, et al.Biorxiv : the Preprint Server for Biology|April 16, 2025
Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially control regulatory T cell phenotype and function via CXCL9 and CCL22Saumya Y Maru, Meredith Wetzel, Jacob T Mitchell, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2026
Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and functionSaumya Y Maru, Meredith Wetzel, Jacob T Mitchell, et al.Clinical Epigenetics|December 3, 2022
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceThatcher R Heumann, Marina Baretti, Elizabeth A Sugar, et al.Clinical & Experimental Metastasis|May 8, 2024
A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancerAaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.Biorxiv : the Preprint Server for Biology|February 14, 2024
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2<sup>+</sup> breast cancerAaron G Baugh, Edgar Gonzalez, Valerie H Narumi, et al.JCI Insight|December 8, 2023
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacyAmanda L Huff, Gabriella Longway, Jacob T Mitchell, et al.Pageof 2